Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway

Antioxidants and Redox Signaling

Volumn 10, Issue 10, 2008, Pages 1699-1712

  Guo, Zhi Jian ^a   Niu, Hong Xin ^a   Hou, Fan Fan ^a   Zhang, Lu ^a   Fu, Ning ^a   Nagai, Ryoji ^b   Lu, Xiao ^a   Chen, Bai Hong ^a   Shan, Yue Xin ^a   Tian, Jian Wei ^a   Nagaraj, Ram H ^c   Xie, Di ^a   Zhang, Xun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b KUMAMOTO UNIVERSITY   (Japan)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED OXIDATION PROTEIN PRODUCT; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; COMPETITIVE INHIBITION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; OXIDATION; PRIORITY JOURNAL; RECEPTOR BINDING; SERUM; SIGNAL TRANSDUCTION; UREMIA;

BINDING, COMPETITIVE; CELLS, CULTURED; ENDOTHELIAL CELLS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE-1; MAP KINASE SIGNALING SYSTEM; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; NF-KAPPA B; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC; SERUM ALBUMIN; SIGNAL TRANSDUCTION; UMBILICAL VEINS; UREMIA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 49749083855     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1999     Document Type: Article

References (48)

1. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, and Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109: 227-233, 2004.
2. Anderson MM, Requena JR, Crowley JR, Thorpe SR, and Heinecke JW. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl) lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 104: 103-113, 1999.
3. Atabek ME, Keskin M, Yazici C, Kendirci M, Hatipoglu N, Koklu E, and Kurtoglu S. Protein oxidation in obesity and insulin resistance. Eur J Pediatr 165: 753-756, 2006.
4. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, and Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130: 1910-1917, 1983.
5. Basta G, Lazzerini G, Massaro M, Simoncini T, Tanganelli P, Fu C, Kislinger T, Stern DM, Schmidt AM, and De Caterina R. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105: 816-822, 2002.
6. Capeillere-Blandin C, Gausson V, Scamps-Latscha B, and Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 1689: 91-102, 2004.
7. Delanian S, Martin M, Bravard A, Luccioni C, and Lefaix JL. Cu/Zn superoxide dismutase modulates phenotypic changes in cultured fibroblasts from human skin with chronic radiotherapy damage. Radiother Oncol 58: 325-331, 2001.
8. Drueke T, Witko-Sarsat V, Massy Z, Scamps-Latscha B, Guerin AP, Marchais SJ, Gausson V, and London GM. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106: 2212-2217, 2002.
9. Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, and Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 97: 1535-1544, 1996.
10. Horiuchi S, Sakamoto Y, and Sakai M. Scavenger receptors for oxidized and glycated proteins. Amino Acids 25: 283-292, 2003.
11. Hou FF. Cardiovascular risk in Chinese patients with chronic kidney diseases: where do we stand? Chin Med J (Engl ) 118: 883-886, 2005.
12. Hou FF, Miyata T, Boyce J, Yuan Q, Chertow GM, Kay J, Schmidt AM, and Owen WF. beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney Int 59: 990-1002, 2001.
13. Jersmann HP, Hii CS, Ferrante JV, and Ferrante A. Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways. Infect Immun 69: 1273-1279, 2001.
14. Kaji Y, Usui T, Oshika T, Matsubara M, Yamashita H, Araie M, Murata T, Ishibashi T, Nagai R, Horiuchi S, and Amano S. Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci 41: 362-368, 2000.
15. Kalousova M, Skrha J, and Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51: 597-604, 2002.
16. Kaneda H, Taguchi J, Ogasawara K, Aizawa T, and Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 162: 221-225, 2002.
17. Kobayashi S, Suzuki M, Tsuneki H, Nagai R, Horiuchi S, and Hagino N. Overproduction of N(epsilon)-(carboxymethyl) lysine-induced neovascularization in cultured choroidal explant of streptozotocin-diabetic rat. Biol Pharm Bull 27: 1565-1571, 2004.
18. Krolewski AS, Warram JH, Valsania P, Martin BC, Laffel LM, and Christlieb AR. Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med 90: 56S-61S, 1991.
19. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, and Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810-17814, 1997.
20. Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM, Tian JW, and Xie D. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soc Nephrol 18: 528-538, 2007.
21. Li JM, Mullen AM, Yun S, Wientjes F, Brouns GY, Thrasher AJ, and Shah AM. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ Res 90: 143-150, 2002.
22. Li JM and Shah AM. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J Biol Chem 278: 12094-12100, 2003.
23. Li T, Chen YH, Liu TJ, Jia J, Hampson S, Shan YX, Kibler D, and Wang PH. Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells. Circ Res 93: 1202-1209, 2003.
24. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, Zhou ZM, Zhou M, Xie D, Wang GB, and Zhang X. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 26: 1156-1162, 2006.
25. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402-408, 2001.
26. Marsche G, Heller R, Fauler G, Kovacevic A, Nuszkowski A, Graier W, Sattler W, and Malle E. 2-chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis. Arterioscler Thromb Vasc Biol 24: 2302-2306, 2004.
27. Menon V, Gul A, and Sarnak MJ. Cardiovascular risk factors in chronic kidney disease. Kidney Int 68: 1413-1418, 2005.
28. Nagai R, Hayashi CM, Xia L, Takeya M, and Horiuchi S. Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J Biol Chem 277: 48905-48912, 2002.
29. Nah SS, Choi IY, Yoo B, Kim YG, Moon HB, and Lee CK. Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes. FEBS Lett 581: 1928-1932, 2007.
30. Nakashima Y, Raines EW, Plump AS, Breslow JL, and Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 18: 842-851, 1998.
31. Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, and Gorlach A. NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 8: 1473-1484, 2006.
32. Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, and Baynes JW. N epsilon- (carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34: 10872-10878, 1995.
33. Sady C, Jiang CL, Chellan P, Madhun Z, Duve Y, Glomb MA, and Nagaraj RH. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins. Biochim Biophys Acta 1481: 255-264, 2000.
34. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, and Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96: 1395-1403, 1995.
35. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, and Clauss M. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267: 14987-14997, 1992.
36. Shan YX, Yang TL, Mestril R, and Wang PH. Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle: implications on decreased myocardial protection in diabetic cardiomyopathy. J Biol Chem 278: 45492-45498, 2003.
37. Sumimoto H, Ueno N, Yamasaki T, Taura M, and Takeya R. Molecular mechanism underlying activation of superoxide-producing NADPH oxidases: roles for their regulatory proteins. Jpn J Infect Dis 57: S24-S25, 2004.
38. Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris K, Penfold S, Bach LA, Cooper ME, and Forbes JM. Inhibition of NADPH oxidase prevents AGE mediated damage in diabetic nephropathy through a protein kinase C-{alpha} dependent pathway. Diabetes 57: 460-469, 2008.
39. Valencia JV, Weldon SC, Quinn D, Kiers GH, DeGroot J, TeKoppele JM, and Hughes TE. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics. Anal Biochem 324: 68-78, 2004.
40. Van Buul JD, Fernandez-Borja M, Anthony EC, and Hordijk PL. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 7: 308-317, 2005.
41. Van Heerebeek L, Meischl C, Stooker W, Meijer CJ, Niessen HW, and Roos D. NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J Clin Pathol 55: 561-568, 2002.
42. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, and Wautier JL. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280: E685-E694, 2001.
43. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, and Scamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49: 1304-1313, 1996.
44. Witko-Sarsat V, Gausson V, Nguyen AT, Touam M, Drueke T, Santangelo F, and Scamps-Latscha B. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 64: 82-91, 2003.
45. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, and Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269: 9889-9897, 1994.
46. Yan SF, Ramasamy R, Naka Y, and Schmidt AM. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93: 1159-1169, 2003.
47. Zhu P, Tang L, Zhao SC, Lu X, Hou FF, and Fu N. Preparation of monoclonal antibodies against different epitopes on extracellular domain of human receptor for advanced glycation end product. Di Yi Jun Yi Da Xue Xue Bao 24: 129-132, 2004.
48. Zund G, Uezono S, Stahl GL, Dzus AL, McGowan FX, Hickey PR, and Colgan SP. Hypoxia enhances induction of endothelial ICAM-1: role for metabolic acidosis and proteasomes. Am J Physiol 273: C1571-C1580, 1997.